RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Zivar Yousefipour to Neoplasms

Back to Details
This is a "connection" page, showing publications Zivar Yousefipour has written about Neoplasms.
Zivar Yousefipour
Connection Strength
0.368
Neoplasms
  1. Ranganna K, Selvam C, Shivachar A, Yousefipour Z. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach. Int J Mol Sci. 2020 Nov 02; 21(21).
    View in: PubMed
    Score: 0.368
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support